Intrinsic Value of S&P & Nasdaq Contact Us

Align Technology, Inc. ALGN NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
$338.84
+83.5%
Analyst Price Target
$197.30
+6.8%

Align Technology, Inc. (ALGN) generated $593.22M in operating cash flow for fiscal year 2025. After capital expenditures of $102.45M, free cash flow was $490.78M.

Free cash flow margin was 12.2% of revenue. Cash conversion ratio was 1.45x, indicating earnings are backed by cash.

The company returned $465.94M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (83/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (71/100, Pass) — $490.78M (12.2% FCF margin) supports a durable competitive advantage
  • INCOME (55/100) — Cash conversion ratio was 1.45x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
VALUE
33/100
Price-to-Earnings & upside
→ Valuation
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
83/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
71/100
Proven by this page
~
GROWTH
55/100
→ Income
~
INCOME
55/100
→ Income
Align Technology, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $593.22M$593.22M$738.23M$785.78M$568.73M
Capital Expenditure $0.00$-102.45M$-115.58M$-177.72M$-291.9M
Free Cash Flow $593.22M$490.78M$622.65M$608.06M$276.83M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message